Increased circulating phenylacetylglutamine concentration elevates the predictive value of cardiovascular event risk in heart failure patientsHaoran Wei, Dao Wen Wang, Chenze Li et al.|Journal of Internal Medicine|2023Cited by 28
Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against heart failure via increasing epoxyeicosatrienoic acidsChengcheng Zhao, Dao Wen Wang, Xiangrui Jiang et al.|Journal of Molecular and Cellular Cardiology|2023Cited by 6